Teriparatide (Forteo®) is a recombinant form of parathyroid hormone, used in the treatment of advanced osteoporosis.

Administration

---

Teriparatide is administered by injection once a day in the thigh or abdomen. The recommended dose is 20 μg per day.

Uses

---

Teriparatide is a third-line agent in osteoporosis, after calcium/vitamin D supplementation and bisphosphonates. The bisphosphonates are effective in a large majority of osteoporosis patients, and only a minority would normally require teriparatide.

More on [ Teriparatide ]

Teriparatide - Twitter Search

Teriparatide may offer therapeutic potential for localized bone defects in the jaw.
rainbrownie (rainbrownie) Thu, 09 Feb 2012 17:32:25 -0000
Teriparatide may offer therapeutic potential for localized bone defects in the jaw.
Teriparatide may offer therapeutic potential for localized bone defects in the jaw.
rainbrownie (rainbrownie) Mon, 06 Feb 2012 17:54:20 -0000
Teriparatide may offer therapeutic potential for localized bone defects in the jaw.
RT @anadue379: Teriparatide, indicaciones de su uso @eforero54 http://t.co/BGWJeR81
eforero54 (Elias Forero Illera) Mon, 06 Feb 2012 01:19:54 -0000
RT @anadue379: Teriparatide, indicaciones de su uso @eforero54 http://t.co/BGWJeR81
Teriparatide, indicaciones de su uso @eforero54 http://t.co/BGWJeR81
anadue379 (ana lucia) Sun, 05 Feb 2012 16:23:36 -0000
Teriparatide, indicaciones de su uso @eforero54 http://t.co/BGWJeR81

Subscribe to Teriparatide RSS feed